COMPANY PROFILE
Pentixapharm AG
AG (Stock Corporation)BerlinResearch and experimental development on biotechnology
FOUNDED
2023
Active
TRADE REGISTER
HRB 269913
Berlin (Charlottenburg)
INDUSTRY
Research and experimental development on biotechnology
SIZE CLASS
Small enterprise
Key questions answered
What does the company do?
Forschung, Entwicklung, einschließlich Durchführung präklinischer und klinischer Studien, sowie Herstellung, Inverkehrbringen und Vertrieb von Arzneimitteln, insbesondere von Radiopharmaka.
Who leads it?
Henner Kollenberg, Dr. Dirk Pleimes
How large is it?
Small enterprise
How stable is it?
Stability assessment in the full profile
Business activity
Industry (WZ2008)
Research and experimental development on biotechnology
WZ M72.11
Size class
Small
Industry (WZ2008) (2)
- M72.11Research and experimental development on biotechnology
- C21.20Manufacture of pharmaceutical preparations
Business purpose
Forschung, Entwicklung, einschließlich Durchführung präklinischer und klinischer Studien, sowie Herstellung, Inverkehrbringen und Vertrieb von Arzneimitteln, insbesondere von Radiopharmaka.
Legal essentials
- Register entry
- HRB 269913 (Berlin (Charlottenburg))
- Legal form
- AG (Stock Corporation)
- Founded
- 05 Sept 2023
- Share capital
- €21,700,000
- VAT ID
- —
- LEI
- 8945005LJQ46NWH30592
- Representation rules
- Ist ein Vorstandsmitglied bestellt, so vertritt es die Gesellschaft allein. Sind mehrere Vorstandsmitglieder bestellt, wird die Gesellschaft durch zwei Vorstandsmitglieder oder durch ein Vorstandsmitglied in Gemeinschaft mit einem Prokuristen vertreten.
Annual statements
No public annual statements on file.
Annual financial statements (PDF)
The most recently published annual financial statements as a PDF, straight from the German company register.
Available once you sign in
Signals
Four dimensions from hard data — age, financials, HRB events, compliance. The ratings themselves are in the full profile.
- Continuity1Available in the full profile
- Financials2Available in the full profile
- Management3Available in the full profile
- Legal status4Available in the full profile
Directors & officers
Executive board
Henner Kollenberg
Board Member
Dr. Dirk Pleimes
Board Member
A further 3 registered persons are in the full profile.
Research contacts
AI-powered research for publicly available contacts: name, role, phone, email, LinkedIn.
Available once you sign in
Recent news
AI-powered research across press, social media and job postings from the last six months.
Available once you sign in
Commercial register history
No events on file.
Companies with a similar profile
Location neighbours
C-E Campus-energy GmbH
Berlin · ⌂ selbes Gebäude
Ariceum Therapeutics GmbH
Berlin · ⌂ selbes Gebäude
Blue Blood GmbH
Berlin · ⌂ selbes Gebäude
ZELL-Zentrum für erlebnisorientiertes Lernen in den Lebenswissenschaften GmbH
Berlin · ⌂ selbes Gebäude
OctreoPharm Sciences GmbH
Berlin · ⌂ selbes Gebäude
E.R.D.E.-AAK-Diagnostik GmbH
Berlin · ⌂ selbes Gebäude
DEVELOPERS
Programmatic access
Three ways to access this company's data programmatically:
- AGENT-CARD
Freely accessible, no API key required — a compact JSON summary for agents and crawlers.
- API
Full, authenticated data via the Implisense API v2 (API key required).
- MCP
MCP server live at mcp.implisense.com (FastMCP, Bearer auth) — usable with ChatGPT, Claude, and your own agents.
Plus opens every profile
Every company profile in full, without spending Implicents on it — plus wider search reach, unlimited lists and the enriched export.
- Revenue, result and equity across every available year
- All four signals with rationale and source
- The full commercial register history — on every profile
- Full search reach instead of the first page of hits
- The enriched Excel export, which Free does not have at all